Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
Location
300 Professional Dr, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 158 % +50%
Quick Ratio 78.3 % +79.6%
Debt-to-equity 203 % +33.4%
Return On Assets -12.3 % +64.2%
Operating Margin -10.4 % +85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.3M shares +3.69%
Common Stock, Shares, Outstanding 54.3M shares +4.02%
Entity Public Float 361M USD -5.25%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 53M shares +3.52%
Weighted Average Number of Shares Outstanding, Diluted 53M shares +3.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.04B USD -0.54%
Research and Development Expense 70.7M USD -36.5%
Operating Income (Loss) -109M USD +85%
Nonoperating Income (Expense) -34.2M USD -613%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -143M USD +80.5%
Income Tax Expense (Benefit) 47.7M USD +62.8%
Net Income (Loss) Attributable to Parent -191M USD +74.9%
Earnings Per Share, Basic -3.6 USD/shares +75.8%
Earnings Per Share, Diluted -3.6 USD/shares +75.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.5M USD -10.9%
Accounts Receivable, after Allowance for Credit Loss, Current 155M USD -19.1%
Inventory, Net 312M USD -5.23%
Assets, Current 599M USD -11.9%
Property, Plant and Equipment, Net 271M USD -29.3%
Operating Lease, Right-of-Use Asset 11.7M USD -27.8%
Intangible Assets, Net (Excluding Goodwill) 502M USD -11.5%
Goodwill 0 USD
Other Assets, Noncurrent 18.9M USD -90.3%
Assets 1.39B USD -23.8%
Accounts Payable, Current 60.9M USD -45.7%
Employee-related Liabilities, Current 56.1M USD -24.3%
Accrued Liabilities, Current 17.7M USD -4.84%
Contract with Customer, Liability, Current 4.8M USD -82.4%
Liabilities, Current 162M USD -75.1%
Deferred Income Tax Liabilities, Net 41.7M USD -11.7%
Operating Lease, Liability, Noncurrent 9.7M USD -29.7%
Other Liabilities, Noncurrent 39.1M USD +35.3%
Liabilities 907M USD -22.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.2M USD +8.77%
Retained Earnings (Accumulated Deficit) -212M USD -874%
Stockholders' Equity Attributable to Parent 483M USD -25.6%
Liabilities and Equity 1.39B USD -23.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.6M USD +66%
Net Cash Provided by (Used in) Financing Activities 40.7M USD
Net Cash Provided by (Used in) Investing Activities -10.8M USD +28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 59.9M shares +3.63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -32.7M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD -5.46%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.5M USD -0.46%
Deferred Tax Assets, Valuation Allowance 339M USD +31.5%
Deferred Tax Assets, Gross 346M USD +28.5%
Operating Lease, Liability 12.4M USD -28.3%
Depreciation 43.7M USD -26.6%
Payments to Acquire Property, Plant, and Equipment 10.8M USD -28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -190M USD +75.3%
Lessee, Operating Lease, Liability, to be Paid 15.3M USD -25%
Property, Plant and Equipment, Gross 668M USD -15.9%
Operating Lease, Liability, Current 2.7M USD -22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.8M USD -24.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.6M USD -16.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.9M USD -6.45%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.2M USD -24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 1.7M USD -74.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.8M USD -21.7%
Additional Paid in Capital 928M USD +2.61%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 65.1M USD -0.76%
Depreciation, Depletion and Amortization 27.9M USD -19.4%
Deferred Tax Assets, Net of Valuation Allowance 7.2M USD -38.5%
Share-based Payment Arrangement, Expense 18M USD -22.1%
Interest Expense 94.3M USD +101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%